Use of untranslated region of osmotin gene to enhance transgene expression in plants
CA 2452131 C · Owner: Liu, Dong · Inventors: Burton, Stephanie Love; Liu, Dong; Glancy, Todd Philip
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides methods vectors and gene constructs for enhancing expression of a recombinant nucleic acid sequence in transgenic plants and plant tissues. According to the present invention nucleic acid sequences are obtained and/or derived from the 5' and 3' untranslated regions of genes encoding osmotin proteins and engineered to flank respective portions of a selected coding region of a vector. The vector construct may be introduced into plants and/or plant tissues through conventional procedures resulting in enhanced expression of the selected coding region. In a preferred embodiment the selected coding region is a chimeric gene or gene fragment expressing one or more …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 6, 2004 and granted March 19, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 6, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 6, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.